Cardiovascular Systems reported six months of fiscal year 2022

Cardiovascular Systems' GAAP loss for 6 months of fiscal year 2022 was $17.585 million, up 8.2 times from $2.132 million in the prior year. Revenue decreased 5.8% to $117.505 million from $124.713 million a year earlier.